Location: Montreal, Quebec, Canada
CIK: 0001274413 · Show all filings
Period: Q3 2014 (← Previous) (Next →)
Filing Date: Nov 13, 2014
Total Value: $2.376B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN IDEC INC | 514,406 | $170M | 7.2% | $238.01 | +38.5% | COM | 09062X103 |
| AMGN | AMGEN INC | 1,177,201 | $165M | 7.0% | $75.69 | +24.9% | COM | 031162100 |
| GILD | GILEAD SCIENCES INC | 1,309,916 | $139M | 5.9% | $37.24 | +82.7% | COM | 375558103 |
| — | CELGENE CORP | 1,364,772 | $129M | 5.4% | $99.53 | — | COM | 151020104 |
| BMRN | BIOMARIN PHARMAC INC | 1,379,000 | $99.51M | 4.2% | $64.27 | +2.3% | COM | 09061G101 |
| — | MYLAN INC | 2,159,851 | $98.25M | 4.1% | $37.65 | — | COM | 628530107 |
| TEVA | TEVA PHARMACEUTICAL | 1,708,191 | $91.81M | 3.9% | $48.10 | — | ADR | 881624209 |
| — | ACTAVIS PLC | 347,850 | $83.93M | 3.5% | $176.97 | — | SHS | G0083B108 |
| REGN | REGENERON PHARMCTCLS | 227,800 | $82.13M | 3.5% | $257.11 | +29.6% | COM | 75886F107 |
| — | ALEXION PHARM INC | 487,408 | $80.82M | 3.4% | $97.89 | — | COM | 015351109 |
| INCY | INCYTE CORPORATION | 1,631,812 | $80.04M | 3.4% | $31.28 | +60.3% | COM | 45337C102 |
| TMO | THERMO FISHER SCI | 524,600 | $63.84M | 2.7% | $96.55 | +21.6% | COM | 883556102 |
| PTCT | PTC THERAPEUTICS I | 1,322,398 | $58.2M | 2.4% | $24.35 | +28.5% | COM | 69366J200 |
| PRGO | PERRIGO CO | 367,568 | $55.2M | 2.3% | $142.01 | +5.0% | SHS | G97822103 |
| — | MALLINCKRODT PLC | 600,464 | $54.13M | 2.3% | $57.67 | — | SHARES | G5785G107 |
| — | KERYX BIOPHARMACEUT | 3,615,126 | $49.71M | 2.1% | $13.93 | — | COM | 492515101 |
| — | ALLERGAN INC | 273,650 | $48.76M | 2.1% | $116.53 | — | COM | 018490102 |
| — | NPS PHARMACEUTICALS | 1,726,824 | $44.9M | 1.9% | $17.82 | — | COM | 62936P103 |
| HALO | HALOZYME THERAPEUTIC | 4,558,982 | $41.49M | 1.7% | $8.25 | +15.5% | COM | 40637H109 |
| — | SYNAGEVA BIOPHARMA | 602,345 | $41.43M | 1.7% | $68.06 | — | COM | 87159A103 |
| RDY | DR REDDYS LABS LTD | 734,947 | $38.62M | 1.6% | $42.90 | — | ADR | 256135203 |
| VRTX | VERTEX PHARMACEUTICL | 329,897 | $37.05M | 1.6% | $73.84 | +28.9% | COM | 92532F100 |
| — | PORTOLA PHARMACEUTIC | 1,412,350 | $35.7M | 1.5% | $25.32 | — | COM | 737010108 |
| — | MEDIVATION INC | 336,878 | $33.31M | 1.4% | $98.21 | — | COM | 58501N101 |
| — | ONCOMED PHARMACEUT | 1,694,517 | $32.08M | 1.3% | $18.89 | — | COM | 68234X102 |
| — | SAGENT PHARMACEUTI | 1,029,472 | $32.02M | 1.3% | $22.38 | — | COM | 786692103 |
| ABBV | ABBVIE INC | 444,107 | $25.65M | 1.1% | $32.24 | +9.1% | COM | 00287Y109 |
| PFE | PFIZER INC | 823,949 | $24.36M | 1.0% | $17.45 | 0.0% | COM | 717081103 |
| — | MOMENTA PHARMACEUTIC | 2,134,440 | $24.2M | 1.0% | $13.18 | — | COM | 60877T100 |
| — | IMMUNOGEN INC | 2,269,597 | $24.04M | 1.0% | $16.54 | — | COM | 45253H101 |
| UTHR | UNITED THERAPEUTICS | 182,400 | $23.47M | 1.0% | $92.88 | +11.0% | COM | 91307C102 |
| — | CHIMERIX INC | 842,149 | $23.26M | 1.0% | $23.36 | — | COM | 16934W106 |
| — | SEATTLE GENETICS INC | 609,819 | $22.67M | 1.0% | $33.81 | — | COM | 812578102 |
| — | ACCELERON PHARMA | 726,424 | $21.97M | 0.9% | $33.26 | — | COM | 00434H108 |
| INSM | INSMED INC | 1,625,323 | $21.21M | 0.9% | $13.61 | +10.8% | COM | 457669307 |
| — | AKORN INC | 584,643 | $21.2M | 0.9% | $15.40 | — | COM | 009728106 |
| — | COVIDIEN PLC | 232,358 | $20.1M | 0.8% | $65.56 | — | SHS | G2554F113 |
| — | SHIRE PLC | 71,536 | $18.53M | 0.8% | $100.74 | — | SPONSORED ADR | 82481R106 |
| — | INTERCEPT PHARMACE | 77,893 | $18.44M | 0.8% | $325.13 | — | COM | 45845P108 |
| ISRG | INTUITIVE SURGIC INC | 37,476 | $17.31M | 0.7% | $42.42 | +17.0% | COM | 46120E602 |
| — | KARYOPHARM THERAPE | 488,342 | $17.06M | 0.7% | $41.33 | — | COM | 48576U106 |
| — | THERAVANCE INC | 971,438 | $16.6M | 0.7% | $38.49 | — | COM | 88338T104 |
| — | RELYPSA INC | 738,573 | $15.58M | 0.7% | $24.21 | — | COM | 759531106 |
| ALGN | ALIGN TECH INC | 268,360 | $13.87M | 0.6% | $40.27 | +35.2% | COM | 016255101 |
| — | VALEANT PHARMA INTL | 95,400 | $12.52M | 0.5% | $130.48 | — | COM | 91911K102 |
| BSX | BOSTON SCIENTIFIC | 1,047,166 | $12.37M | 0.5% | $9.54 | +32.0% | COM | 101137107 |
| — | NXSTAGE MEDICAL | 881,732 | $11.58M | 0.5% | $13.78 | — | COM | 67072V103 |
| — | TORNIER N V | 469,023 | $11.21M | 0.5% | $18.23 | — | SHS | N87237108 |
| DXCM | DEXCOM INC | 276,266 | $11.05M | 0.5% | $7.85 | +30.2% | COMMON | 252131107 |
| — | HEARTWARE INTL INC | 138,849 | $10.78M | 0.5% | $91.53 | — | COM | 422368100 |
| — | CIGNA CORP | 103,164 | $9.356M | 0.4% | $91.74 | — | COM | 125509109 |
| AMPH | AMPHASTAR PHARMACTLS | 660,232 | $7.692M | 0.3% | $10.42 | 0.0% | COM | 03209R103 |
| NVO | NOVO-NORDISK AS | 147,185 | $7.009M | 0.3% | $60.40 | — | ADR | 670100205 |
| INGN | INOGEN INC | 251,600 | $5.185M | 0.2% | $17.78 | +14.2% | COM | 45780L104 |
| — | CYMABAY THERAPEUTICS | 708,585 | $4.847M | 0.2% | $6.84 | — | COMMON | 23257D103 |
| NVS | NOVARTIS AG | 41,600 | $3.916M | 0.2% | $83.42 | — | SPONSORED ADR | 66987V109 |
| — | AMBIT BIOSCIENCES | 146,111 | $2.25M | 0.1% | $15.40 | — | COM | 02318X100 |
| — | IMMUNE DESIGN CORP | 95,000 | $1.678M | 0.1% | $17.66 | — | COM | 45252L103 |
| — | TANDEM DIABETES CA | 101,422 | $1.361M | 0.1% | $17.42 | — | COM | 875372104 |
| — | ELEVEN BIOTHERAPEU | 112,485 | $1.253M | 0.1% | $11.14 | — | COM | 286221106 |
| PRQR | PROQR THRAPEUTICS | 70,000 | $1.203M | 0.1% | $16.02 | 0.0% | SHS EURO | N71542109 |
| FOLD | AMICUS THERAPEUTICS | 200,000 | $1.19M | 0.1% | $5.24 | 0.0% | COM | 03152W109 |
| — | ALDER BIOPHARMACEU | 89,300 | $1.132M | 0.0% | $16.03 | — | COM | 014339105 |
| — | PROSENSA HLDGS | 94,184 | $794K | 0.0% | $11.80 | — | SHS USD | N71546100 |
| — | WUXI PHAR ADS | 18,873 | $661K | 0.0% | $35.41 | — | SPONS ADR SHS | 929352102 |
| — | ANTHERA PHARMACEUT | 247,961 | $476K | 0.0% | $3.19 | — | COM | 03674U201 |